Craft

ChromaDex

Stock Price

$3.6

2024-10-29

Market Capitalization

$279.4 M

2024-10-29

Revenue

$129.4 M

FY, 2025

ChromaDex Summary

Company Summary

Overview
ChromaDex Corporation discovers, acquires, develops, and commercializes proprietary-based ingredient technologies. The Company allows its business units to discover, acquire, develop and commercialize ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. The Company operates through three segments: Ingredients, which develops, supplies and commercializes ingredient technologies; Core standards and contract services, which supplies phytochemical reference standards; and Scientific and regulatory consulting, which provides scientific and regulatory consulting to the clients in the food, supplement and pharmaceutical industries to manage health and regulatory risks.
Type
Public
Status
Active
Founded
1999
HQ
Irvine, CA, US | view all locations
Website
https://www.chromadex.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Robert Fried

    Robert Fried, Chief Executive Officer, Director

  • Steven D. Rubin

    Steven D. Rubin, Non-Executive Director

    • Wendy Yu

      Wendy Yu, Non-Executive Director

      • Charles Brenner

        Charles Brenner, Chief Scientific Advisor

      LocationsView all

      4 locations detected

      • Irvine, CA HQ

        United States

        10005 Muirlands Blvd

      • Longmont, CO

        United States

        1751 S Fordham St #350

      • Los Angeles, CA

        United States

        11150 Santa Monica Blvd Suite 600

      • Rockville, MD

        United States

        11821 Parklawn Dr #310

      ChromaDex Financials

      Summary Financials

      Revenue (Q1, 2026)
      $31.5M
      Gross profit (Q1, 2026)
      $20.0M
      Net income (Q1, 2026)
      $6.3M
      Cash (Q1, 2026)
      $66.5M
      EBIT (Q1, 2026)
      $1.6M
      Enterprise value
      $215.5M

      Footer menu